Nalaganje...
States Try to Control Medicaid Pharmaceutical Costs: Numerous, Diverse Cost Pressures Force Myriad Reform Efforts
State Medicaid programs and the managed care plans that insure most recipients are struggling with the costs of hepatitis C medications and other specialty drugs that may be only the leading edge of a wave of expensive treatments for common conditions.
Shranjeno v:
| izdano v: | P T |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MediMedia USA, Inc.
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4378518/ https://ncbi.nlm.nih.gov/pubmed/25859120 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|